SANOFI-AVENTIS U S
Updated 497 days ago
Wolters Kluwer; 2018. 2. Cairo MS
References: 1. Cortes J, Moore JO, Maziarz RT, et al. Control of plasma uric acid in adults at risk for tumor lysis syndrome: efficacy and safety of rasburicase alone and rasburicase followed by allopurinol compared with allopurinol alone-results of a multicenter phase III study. J Clin Oncol. 2010;28(27):4207-4213. 2. Jakić-Razumović J, Aurer I. The World Health Organization classification of lymphomas. Croat Med J. 2002;43(5):527-534. 3. Nicolaides C, Dimou S, Pavlidis N. Prognostic factors in aggressive non-Hodgkin's lymphomas. Oncologist. 1998;3(3):189-197. 4. ELITEK [prescribing information]. Bridgewater, NJ: sanofi-aventis U.S. LLC.
Also known as: sanofi-aventis U.S. LLC